Ticker

Analyst Price Targets — LXRX

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 12, 2026 4:26 pmJoseph PantginisH.C. Wainwright$6.00$1.70StreetInsider H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX): "significant upside potential exists"
October 18, 2024 5:48 amRoanna RuizLeerink Partners$6.00$2.01StreetInsider Lexicon Pharmaceuticals (LXRX) PT Raised to $6 at Leerink Partners

Latest News for LXRX

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for LXRX.

No House trades found for LXRX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top